Records containing: Respiratory Disorders

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2026-02-17
  Use of Hyperpolarized 129 Xe MR Lung Imaging in Children and Adults
• CLINICAL_TRIALS study record update · 2025-09-10
  Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration
• CLINICAL_TRIALS study record update · 2025-06-11
  The Effect of 10 Weeks of Physical Exercise on Glycated Hemoglobin and Blood Pressure in Elderly People With Multimorbidity Conditions: a Controlled and Randomized Study
• CLINICAL_TRIALS study record update · 2025-04-30
  Functional Efficiency, Respiratory Parameters and Blood Rheological Tests in Elderly People With Respiratory Diseases Participating in Pulmonary Rehabilitation in Underground Salt Chambers - a Prospective Experimental Study, Controlled in a Crossover Design
• CLINICAL_TRIALS study record update · 2021-09-27
  Immunogenicity and Safety Study of GSK's Investigational Vaccine (GSK3277511A) When Administered in Healthy Smokers and Ex-smokers Following Receipt of Shingrix Vaccine
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2021-06-14
  Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease (COPD) and During Acute Exacerbations of COPD (AECOPD), in Asia Pacific
• CLINICAL_TRIALS study record update · 2021-04-08
  A Long-term Follow-up Study of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults
• CLINICAL_TRIALS study record update · 2021-01-11
  An Observer-blind Study to Evaluate the Efficacy, Safety, Reactogenicity and Immunogenicity of the GSK Biologicals' Investigational Vaccine GSK3277511A When Administered to COPD Patients
• CLINICAL_TRIALS study record update · 2020-11-12
  An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' COPD Vaccine (GSK3277511A) in Adults
• CLINICAL_TRIALS study record update · 2020-08-14
  Hemodynamic Repercussions of Ventilator Hyperinflation Using Volume-controlled Ventilation: a Randomized Controlled Trial
• CLINICAL_TRIALS study record update · 2019-06-27
  A Two-part, Randomised, Placebo-controlled Study to Investigatethe Safety, Tolerability, Pharmacokinetics and Pharmacodynamicsof Single Doses of Inhaled GSK1995057 in Healthy Subjects
• CLINICAL_TRIALS study record update · 2019-02-15
  Contribution of Infectious Pathogens to Acute Respiratory Illness in Adults and Elderly
• CLINICAL_TRIALS study record update · 2019-02-08
  ClinicalTrials.gov study NCT01505556
• CLINICAL_TRIALS study record update · 2018-08-01
  An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients
• CLINICAL_TRIALS study record update · 2018-07-23
  An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
• CLINICAL_TRIALS study record update · 2017-06-12
  A Two-part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamicsof Single and Repeat Doses of Intravenously Infused GSK1995057 in Healthy Subjects.
• CLINICAL_TRIALS study record update · 2017-05-16
  Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
• CLINICAL_TRIALS study record update · 2017-05-15
  An Open-label, Randomised, Single Dose, Three-Way Crossover, Six Sequence, Pilot Study to Determine the Relative Bioavailability of Montelukast Sodium 5mg From Two Candidate Chewable Tablet Formulations of GW483100 Relative to One 5mg Chewable Tablet of Reference Montelukast Sodium in Healthy Adult Subjects Under Fasting Conditions
• CLINICAL_TRIALS study record update · 2017-05-15
  An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Healthy Adults
• CLINICAL_TRIALS study record update · 2017-05-15
  An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
• CLINICAL_TRIALS study record update · 2017-05-15
  A Three Part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of Inhaled and Intravenous GSK2862277 in Healthy Volunteers
• CLINICAL_TRIALS study record update · 2017-05-09
  An Open-label Balanced, Randomised, Single Dose, Two-way Crossover Study to Determine the Bioequivalence of GW483100 10 mg Tablets (Containing Montelukast Sodium Equivalent to 10 mg of Montelukast) Relative to Reference Montelukast Sodium 10 mg Tablets (Containing Montelukast Sodium Equivalent to 10 mg of Montelukast) in Healthy Male and Female Volunteers Under Fasting Conditions
• CLINICAL_TRIALS study record update · 2017-03-07
  A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD) Aged Between 45-75 Years
• CLINICAL_TRIALS study record update · 2017-01-25
  Study to Evaluate the Effect of Roflumilast 500 μg on Exacerbation Rate in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Treated With a Fixed-Dose Combination of Long-Acting Beta Agonist and Inhaled Corticosteroid (LABA/ICS)
• CLINICAL_TRIALS study record update · 2014-07-03
  Timing of Elective Caesarean Section and Neonatal Morbidity - a Randomised Multicentre Study